Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that patient dosing is now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback